BlackRock Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $14K | Sell |
3,197
-1
| -0% | -$4 | ﹤0.01% | 3468 |
|
|
2016
Q3 | $31K | Buy |
3,198
+962
| +43% | +$9.33K | ﹤0.01% | 3288 |
|
|
2016
Q2 | $13K | Sell |
2,236
-53,528
| -96% | -$311K | ﹤0.01% | 3517 |
|
|
2016
Q1 | $425K | Buy |
55,764
+1,023
| +2% | +$7.8K | ﹤0.01% | 2948 |
|
|
2015
Q4 | $729K | Buy |
54,741
+451
| +0.8% | +$6.01K | ﹤0.01% | 2801 |
|
|
2015
Q3 | $893K | Sell |
54,290
-5,683
| -9% | -$93.5K | ﹤0.01% | 2671 |
|
|
2015
Q2 | $1.35M | Buy |
59,973
+14,259
| +31% | +$320K | ﹤0.01% | 2549 |
|
|
2015
Q1 | $447K | Buy |
45,714
+7,956
| +21% | +$77.8K | ﹤0.01% | 3000 |
|
|
2014
Q4 | $430K | Buy |
37,758
+573
| +2% | +$6.53K | ﹤0.01% | 3067 |
|
|
2014
Q3 | $428K | Buy |
37,185
+3,987
| +12% | +$45.9K | ﹤0.01% | 3040 |
|
|
2014
Q2 | $645K | Buy |
+33,198
| New | +$645K | ﹤0.01% | 2885 |
|